Cutler Group LP Prothena Corp Public LTD CO Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Cutler Group LP holds 3,700 shares of PRTA stock, worth $54,020. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,700
Previous 14,200
73.94%
Holding current value
$54,020
Previous $132,000
31.06%
% of portfolio
0.03%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding PRTA
# of Institutions
184Shares Held
42.7MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$169 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$61 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$56.3 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$55.8 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$25.4 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $685M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...